Combination of an EGFR blocker and a COX-2 inhibitor for the treatment of advanced cutaneous squamous cell carcinoma.
Jalili A, Pinc A, Pieczkowski F, Karlhofer FM, Stingl G, Wagner SN.
J Dtsch Dermatol Ges. 2008 Dec;6(12):1066-9. English, German.
PMID: 19138272
DOI: 10.1111/j.1610-0387.2008.06861.x
Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck.
Chen Z, Zhang X, Li M, Wang Z, Wieand HS, Grandis JR, Shin DM.
Clin Cancer Res. 2004 Sep 1;10(17):5930-9.
PMID: 15355926
Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck.
Cohen EE, Halpern AB, Kasza K, Kocherginsky M, Williams R, Vokes EE.
Oral Oncol. 2009 Oct;45(10):e155-60. Epub 2009 Jul 7.
PMID: 19586795